US Broker Ratings

Zenas BioPharma, Inc. (ZBIO): Unlocking a Potential 117.96% Upside in the Biotech Sector

Zenas BioPharma, Inc. (ZBIO), a clinical-stage biotechnology company, has captured the attention of investors with its transformative approach to immunology-based therapies. Headquartered in Waltham, Massachusetts, Zenas BioPharma is focused on..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Promising 55.74% Upside Potential in Precision Medicine

Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning name in the biotechnology sector, is making significant strides in the development of precision medicines, primarily targeting fibroblast growth factor receptor (FGFR) biology...

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotech with 37.54% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK) stands prominently in the biotech sector, drawing significant attention from investors with its innovative approach to addressing severe genetic diseases. Specializing in antisense oligonucleotides (ASOs)..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating the Healthcare Sector with Modest Growth Potential

Enhabit, Inc. (EHAB), a key player in the healthcare sector, focuses on providing home health and hospice services across the United States. With a market capitalization of $705.38 million, Enhabit..

Weave Communications, Inc. (WEAV) Stock Analysis: A 44.63% Upside Potential in Healthcare Tech

Weave Communications, Inc. (NASDAQ: WEAV) is making waves in the healthcare technology sector with its robust AI-powered communication platform tailored for small and medium-sized healthcare businesses. As the company continues..

Nuvation Bio Inc. (NUVB) Investor Outlook: Exploring the 156% Potential Upside in Cancer Drug Innovation

Nuvation Bio Inc. (NASDAQ: NUVB) is capturing attention in the biotechnology sector with a notable potential upside of 156.41%, as indicated by its average target price of $12.33. This promising..

Community Health Systems, Inc. (CYH) Investor Outlook: Assessing the 14.29% Potential Upside

Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, operates primarily in the medical care facilities industry. With a market capitalization of $408.66 million, the company..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a Potential 37% Upside with Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector specializing in the development of pain management medications, is currently capturing the attention of investors with its promising..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech with 59.82% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing the attention of investors with its promising potential in the biotechnology sector. As a clinical-stage biopharmaceutical company, Trevi Therapeutics is pioneering innovative treatments..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Exploring a 210% Potential Upside Amidst Biotech Innovations

For investors seeking opportunities in the biotechnology sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) presents an intriguing proposition. With its focus on healthy aging products and a notable potential upside, NAGE..

Replimune Group, Inc. (REPL) Stock Analysis: Navigating the Biotech Landscape with a 4.79% Potential Upside

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative oncolytic immunotherapy product candidates. As the company continues its journey to..

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Navigating Biotechnology Prospects with a 16.75% Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a notable player in the healthcare sector, specifically within the biotechnology industry. Headquartered in San Diego, California, Maravai provides essential products and..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A High-Risk Bet with 153% Upside Potential

Investors with a penchant for high-risk, high-reward opportunities may find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) an intriguing prospect. The biopharmaceutical company, with a market capitalization of $1.59 billion, is a..

iRadimed Corporation (IRMD) Stock Analysis: Unpacking a 36.81% Potential Upside with Strong Buy Ratings

Investors looking for compelling opportunities in the healthcare sector should turn their attention to iRadimed Corporation (NASDAQ: IRMD), a leading developer and manufacturer of MRI-compatible medical devices. With a market..

GH Research PLC (GHRS) Stock Analysis: Biotech Innovator with 86.82% Potential Upside

GH Research PLC (NASDAQ: GHRS), a promising player in the biopharmaceutical sector, is garnering significant investor attention due to its innovative approach to treating mental health disorders. Based in Dublin,..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring a Potential 53% Upside with Strong Buy Ratings

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands as a compelling investment opportunity in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Cambridge, Massachusetts, this clinical-stage..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Unpacking Growth Potential Amidst Analyst Optimism

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a beacon in the biotechnology sector, is drawing significant attention from investors due to its ambitious pipeline and promising market positioning. With a market capitalization..

Upstream Bio, Inc. (UPB) Stock Analysis: A Promising 384.94% Potential Upside in the Biotech Sector

Upstream Bio, Inc. (NASDAQ: UPB) is gaining attention in the investment community with its remarkable potential upside of 384.94%, according to recent analyst ratings. As a clinical-stage biotechnology company, Upstream..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unveiling a Potential 124% Upside for Investors

Vir Biotechnology, Inc. (VIR) stands at a pivotal moment in its growth trajectory, presenting a remarkable investment opportunity for those interested in the healthcare sector, particularly within biotechnology. Headquartered in..

CeriBell, Inc. (CBLL) Stock Analysis: A Promising 35% Upside in the Medical Devices Sector

CeriBell, Inc. (NASDAQ: CBLL), a rising star in the healthcare sector, is capturing the attention of investors with its innovative medical device solutions and a substantial potential upside of 35.29%...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds